Aetna Heads A $25 Million Investment Round Into MAP Health Management

March 7, 2019  

Austin, Texas-based Company blends technology and peer support services to substantially reduce post addiction treatment relapse

Austin, Texas – March 07, 2019 – MAP Health Management (“MAP”), the nation’s leading provider of peer recovery support services and data insights for people with Substance Use Disorders, today announced the completion of a $25 million placement of Series A preferred and common units in a round headed by Aetna, a CVS Health business. Also participating in the round were the Levenson Family and several other private investors.

Led by Founder and CEO, Jacob Levenson, MAP focuses on improving and measuring post-treatment clinical outcomes primarily through the implementation of longer-term support. The personalized support is conducted, via phone or video sessions, by certified peer recovery specialists who leverage both lived experience in recovery and extensive training to engage and support individuals and their families through the difficult and lengthy transition from treatment to long-term recovery.

MAP, who is working with the nation’s leading health insurance companies and treatment providers, will use the funding to expand the company’s geographical base of operations and its patient enrollment strategy beyond addiction treatment providers to also include emergency care locations, primary care providers and pharmacies.

Antonio J Rocchino, Sr. Director of Network Management, at Aetna said, “Aetna and MAP have built a strong collaborative relationship over the last four years. We continue to expand our relationship with MAP and believe that MAP’s services are effectively helping Aetna members in their recovery from Alcohol and Drug Addiction. In providing peer support to our members and their families in their behavioral health recovery journey, MAP’s services support one of the core components in our work to transform behavioral health service delivery. We look forward to a continued and expanded relationship with MAP as a valued partner.”

“After eight years of successful operations, MAP is very excited to welcome Aetna as an investor to enhance the company’s capacity to accomplish its critical mission. The human toll of the opioid and addiction epidemics is totally unacceptable. MAP is in an excellent position to have considerable impact on this chronic disease from which over 23 million Americans suffer,” Levenson said.

About MAP Health Management

From its inception in 2011, MAP’s mission has been to improve outcomes for the millions of people annually diagnosed and treated for the chronic disease of addiction, formally referred to as Substance Use Disorder. MAP delivers a much-needed long-term support model by deploying a suite of proprietary solutions including tech-enabled peer recovery support services, an adaptive engagement framework and outcomes reporting – all designed to improve health outcomes for individuals and reduce preventable healthcare cost. For more information, visit

About Aetna

Aetna, a CVS Health business, serves an estimated 39 million people with information and resources to help them make better informed decisions about their health care. Aetna offers a broad range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental and behavioral health plans, and medical management capabilities, Medicaid health care management services, workers' compensation administrative services and health information technology products and services. Aetna's customers include employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups and expatriates. For more information, visit and explore how Aetna is helping to build a healthier world. @AetnaNews